Senate Democrats Push to Halt Medicare AI Prior Authorizations

Under the pilot program, the federal government partners with private companies to apply AI-backed prior authorization reviews to selected medical procedures. The targeted services include treatments considered vulnerable to fraud or overuse, such as skin substitutes and epidural steroid injections.

Regulators argue the model is narrowly focused and designed to reduce inappropriate care while protecting patients. Officials say the system could help lower unnecessary healthcare spending across the Medicare program.

However, the proposal has triggered strong criticism from providers and lawmakers. Many healthcare professionals argue prior authorization creates delays in patient care and increases administrative burdens for doctors and hospitals.

Senate Democrats Challenge Medicare AI Authorization Pilot

Democratic lawmakers have increasingly pushed back against the WISeR pilot since its announcement. Critics argue the program introduces unnecessary barriers into traditional Medicare, where prior authorization has historically been uncommon.

Last year, House Democrats introduced legislation aimed at repealing the pilot program, although the proposal did not gain significant momentum in Congress.

In April, Maria Cantwell released a report showing that procedures subject to prior authorization in Washington state were experiencing significantly longer approval times.

According to the report, some approvals were delayed for weeks, creating additional paperwork and frustration for both healthcare providers and Medicare patients.

GAO Ruling Opens Door for Congressional Action

Democrats are now pursuing another strategy to overturn the pilot through the Congressional Review Act. The law allows Congress to review and potentially repeal federal agency rules through a formal legislative process.

The Government Accountability Office recently determined that the WISeR model qualifies as agency rulemaking and is therefore subject to congressional review requirements.

Previously, the U.S. Department of Health and Human Services argued the program was only guidance and did not need to be submitted to Congress under the law.

The GAO disagreed, stating that the pilot establishes new requirements within traditional Medicare that directly affect both providers and beneficiaries.

Read : Josh Hart Overcomes Shooting Slump in Knicks Playoff Run

Lawmakers Push for Vote to Repeal WISeR Model

The GAO decision has triggered a 60-day period during which lawmakers can force a congressional vote on repealing the pilot program.

Senate Democrats are now organizing support for a formal resolution aimed at overturning the Medicare AI prior authorization initiative.

Twenty senators have already signed onto the effort, including Ruben Gallego, Ed Markey, Cory Booker, and Dick Durbin.

The debate highlights growing concerns over the use of AI-driven prior authorization systems in healthcare. Lawmakers, providers, and regulators continue to disagree over whether such technologies reduce waste or create harmful delays in patient care.